(Q36715371)

15 August 2017

1 reference

title

Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action (English)

1 reference

attention deficit hyperactivity disorder

15 August 2017

1 reference

1 reference

Steven R Pliszka

1

1 reference

15 August 2017

publication date

1 March 2007

1 reference

15 August 2017

published in

Neuropsychology Review

1 reference

15 August 2017

volume

17

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

61-72

1 reference

https://scigraph.springernature.com/pub.10.1007/s11065-006-9017-3

15 August 2017

exact match

0 references

cites work

Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents

1 reference

https://api.crossref.org/works/10.1007%2FS11065-006-9017-3

Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-006-9017-3

Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-006-9017-3

The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-006-9017-3

Treatment of ADHD in children with tics: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-006-9017-3

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-006-9017-3

Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-006-9017-3

Inhibitory control in children with attention-deficit/hyperactivity disorder: event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism.

21 January 2018

1 reference

12 December 2020

Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder

1 reference

12 December 2020

Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD.

1 reference

12 December 2020

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

12 December 2020

Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop

1 reference

12 December 2020

Electrophysiological activity underlying inhibitory control processes in normal adults.

1 reference

12 December 2020

The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder

1 reference

12 December 2020

Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children

1 reference

12 December 2020

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.

1 reference

12 December 2020

Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study

1 reference

12 December 2020

Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

The use of tricyclic antidepressants in children and adolescents

1 reference

12 December 2020

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder

1 reference

12 December 2020

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A post hoc analysis of d-threo-methylphenidate hydrochloride (focalin) versus d,l-threo-methylphenidate hydrochloride (ritalin).

1 reference

12 December 2020

The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder.

1 reference

12 December 2020

Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder

1 reference

12 December 2020

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

1 reference

12 December 2020

In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter

1 reference

12 December 2020

Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies.

1 reference

12 December 2020

Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity

1 reference

12 December 2020

Growth on stimulant medication; clarifying the confusion: a review

1 reference

12 December 2020

Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

1 reference

12 December 2020

The effect of methylphenidate on response inhibition and the event-related potential of children with attention deficit/hyperactivity disorder

1 reference

12 December 2020

Effects of degradation of visual stimulation on components of the event-related potential (ERP) in go/nogo reaction tasks

1 reference

12 December 2020

Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain

1 reference

12 December 2020

1 reference

12 December 2020

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.

1 reference

12 December 2020

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

12 December 2020

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

1 reference

12 December 2020

Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.

1 reference

12 December 2020

EEG correlates of methylphenidate response in ADHD: association with cognitive and behavioral measures

1 reference

12 December 2020

Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A Positron Emission Tomography Study Of Methylphenidate in Adults with ADHD: Alterations in Resting Blood Flow and Predicting Treatment Response

1 reference

12 December 2020

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

12 December 2020

Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.

1 reference

12 December 2020

Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).

1 reference

12 December 2020

Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.

1 reference

12 December 2020

Electroencephalogram differences in two subtypes of attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment.

1 reference

12 December 2020

ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study

1 reference

12 December 2020

Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders

1 reference

12 December 2020

Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions

1 reference

12 December 2020

Cognitive event-related potentials in attention deficit disorder

1 reference

12 December 2020

Clinical utility of EEG in attention deficit hyperactivity disorder

1 reference

12 December 2020

A review of electrophysiology in attention-deficit/hyperactivity disorder: II. Event-related potentials.

1 reference

12 December 2020

Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography.

1 reference

12 December 2020

Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder

1 reference

12 December 2020

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review.

1 reference

12 December 2020

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder

1 reference

12 December 2020

Dopamine transporter in attention-deficit hyperactivity disorder normalizes after cessation of methylphenidate

1 reference

12 December 2020

Does Prolonged Therapy With a Long-Acting Stimulant Suppress Growth in Children With ADHD?

1 reference

12 December 2020

Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.

1 reference

12 December 2020

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

1 reference

12 December 2020

Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders

1 reference

12 December 2020

Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD.

1 reference

12 December 2020

Suicidality in pediatric patients treated with antidepressant drugs

1 reference

12 December 2020

A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD.

1 reference

12 December 2020

EEG differences between good and poor responders to methylphenidate and dexamphetamine in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation

1 reference

12 December 2020

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

1 reference

12 December 2020

Functional effects of the DAT1 polymorphism on EEG measures in ADHD.

1 reference

12 December 2020

Lack of effects of guanfacine on executive and memory functions in healthy male volunteers

1 reference

12 December 2020

Stimulant treatment over 5 years: effects on growth.

1 reference

12 December 2020

A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder

1 reference

12 December 2020

Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate

1 reference

12 December 2020

Proceed, with caution: SPECT cerebral blood flow studies of children and adolescents with attention deficit hyperactivity disorder.

1 reference

12 December 2020

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

12 December 2020

10.1007/S11065-006-9017-3

Identifiers

DOI

1 reference

15 August 2017

1 reference